肿瘤标志物CA19-9 CEA CA242联合检测在诊断胰腺癌及评估预后的临床意义

Role of Combined Testing of Tumor Markers CA19-9 and CEA and CA242 in the Diagnosis and Evaluate Prognosis of Pancreatic Carcinoma

目的探讨CA19-9、CEA、CA242联合检测在诊断胰腺癌的临床意义。方法采集胰腺疾病患者血清98例,健康人血清60例,测定CA19-9、CEA、CA242。结果胰腺癌组测定值明显高于胰腺炎及正常对照组。结论CA19-9、CEA、CA242联合检测对胰腺癌的诊断、疗效观察及复发预测是较理想的指标。

Objective To explore the value of combined testing of tumor markers CA19 - 9 and CEA and CA242 in the diagnosis of pancreatic carcinoma. Methods Detection of serum tumor markers CA19 - 9 and CEA and CA242 was carried out in 98 patients with pancreatic carcinoma and 60 healthy volunteers. Results The levels of tumor markers in pancreatic carcinoma group were significantly higher than those in the normal contral group. Conclusion THe combined testing of tumor markers CA19 - 9 and CEA and CA242 is an ideal markers in the diagnosis and the follow- up of operated cases and evaluate prognosis of pancreatic carcinoma.